Temper cancer care innovations with cost considerations

There may be new breakthroughs announced in cancer care every few months, but the healthcare sector needs to keep in mind something else: Whether the treatments are cost-effective. Paul Keckley, managing director at the Navigant Center for Healthcare Research and Policy Analysis, noted that cancer care costs will reach $173 billion annually by the end of the decade, while oncology costs have risen 20 times faster than the Consumer Price Index over the past 15 years. As a result, Keckley noted that cancer care outcomes are "not guaranteed by our rich legacy--until and unless the relative value question about cancer care management is addressed forthrightly in a meaningful public discussion, its future is uncertain, reserved for fewer and fewer who can afford it." >> Read the full article at FierceHealthcare

 

Suggested Articles

HIMSS21 conference organizers shared more details Friday about moving the major health IT event to August 2021, including feedback from exhibitors.

A federal appeals court ruled HHS has the legal authority to cut 340B drug payment rates by nearly 30%, dealing another legal blow to hospitals.

Abacus Insights launches a new interoperability solution to help health plans comply and has been certified as a CMS qualified entity.